REMISSION PERIOD IN CHILDREN AND ADOLESCENTS WITH TYPE 1 DIABETES
Journal Title: Romanian Journal of Diabetes Nutrition and Metabolic Diseases - Year 2011, Vol 18, Issue 3
Abstract
Type 1 diabetes mellitus (DM) is characterized by a progressive autoimmune destruction of pancreatic beta cells, process that can be influenced by clinical and metabolic factors. The objective was to identify those factors that might influence residual pancreatic beta cell function and installation of remission period. The study was performed on a group of 56 cases, aged between 2 and 18 years, who were evaluated for their clinical characteristics, frequency and duration of remission, factors that influence remission phase. Remission period was defined as a requirement of insulin < 0.5 U/kg/day. There was partial remission in 25 cases (44.6%), gender repartition was 11 boys: 14 girls. Remission was present in 17 cases (68%) within the first 3 months after the diagnosis of DM was established. Duration of remission ranged from 2 to 24 months. Young children aged between 2 and 5 years have shown partial remission periods in a much lower percentage (28%) than school-age children between 6 and 12 years (72%). At the onset of diabetes, 13 cases (52%) had mild form of diabetic ketoacidosis (DKA) and 10 cases (40%) had moderate form of DKA. The results have shown that both age and severe symptoms at onset were associated with a greater destruction of pancreatic beta cells and a low rate of remission phase.
Authors and Affiliations
Rodica Elena Stefanescu, Ileana Puiu, Maria Mota, Robert Dinu, Ioana Felicia Opritoiu, Alexandra Oltea Puiu
Keywords
Related Articles
- EP ID EP150536
- DOI -
- Views 88
- Downloads 0
SLEEP APNEA AND TYPE 2 DIABETES: A SHORT REVIEW OF THE LITERATURE
The prevalence of diabetes and obesity has reached epidemic proportions. Even if today it is an accepted fact that diet and reduced physical activity are causes of obesity epidemic, sleep disturbances are seen as r...
METABOLIC SYNDROME IN PATIENTS WITH T1DM OLDER THAN 10 YEARS
Metabolic Syndrome (MS) is a clinical entity recently individualized, a clinical concept with multiple definitions that expresses a complex disorder of the body′s energy metabolism, with insulin resistance and compensato...
FFECT OF LIRAGLUTIDE ON CARDIOVASCULAR RISK FACTORS AND FUNCTION
Cardiovascular disease is the major cause of death in diabetes. This results from a cluster of risk factors, including high glucose, obesity, hypertension and dyslipidaemia. Liraglutide is the first native GLP-1 analogue...
A DISEASE CAN BE NEITHER HEALTHY, NOR BENIGN
THE LINK BETWEEN DIABETES, DIABETES TREATMENT AND CANCER
Diabetes mellitus (DM) and cancer are serious diseases, representing a great social burden worldwide and their association has been studied over the years. Several risk factors are common to both DM and cancer and result...